[144] US Physical Therapy Inc SEC Filing

Rhea-AI Filing Summary

US Physical Therapy Inc (USPH) filed a Form 144 notifying a proposed sale of 2,000 Class A common shares through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $169,570.50. The filing shows those shares were acquired by the seller through vesting of restricted stock awards granted between 8/16/2021 and 2/24/2025, received in three vesting events on 7/01/2024 (1,045 shares), 10/01/2024 (305 shares), and 1/01/2025 (650 shares). The proposed approximate date of sale is 08/19/2025. The filer certifies they are not aware of undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: Routine insider notice of intended sale of vested equity, modest in size relative to outstanding shares.

The filing documents a proposed sale of 2,000 shares acquired via equity compensation vesting. At an aggregate stated market value of $169,570.50, the transaction represents a small fraction of the reported 15,094,987 shares outstanding (approximately 0.013%). This appears to be a routine liquidity event by an insider or insider-related person rather than a corporate development or operational signal. No recent sales in the prior three months were reported, and the sale is placed with a major broker, J.P. Morgan Securities LLC, on the NYSE.

Corporate Governance Specialist

TL;DR: Standard Rule 144 notice tied to vesting of restricted stock; disclosure aligns with compliance norms.

The notice links the shares to equity compensation vesting spanning multiple grant dates, and the signer affirms absence of undisclosed material adverse information. This aligns with Rule 144 compliance and typical post-vesting disposition procedures. There is no indication of accelerated insider selling, large aggregated dispositions, or any planned sales linked to nonpublic corporate events in the form text provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	J.P. Morgan Securities LLC 390 Madison Avenue Floor 6 New York NY 10017	2000	169570.5	15094987	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/01/2024	Vesting of Restricted stock Grants issued from 8/16/2021 through 2/24/2025	US Physical Therapy (issuer)			1045	08/20/2025	Equity Compensation
Common	10/01/2024	Vesting of Restricted stock Grants issued from 8/16/2021 through 2/24/2025	US Physical Therapy (issuer)			305	08/20/2025	Equity Compensation
Common	01/01/2025	Vesting of Restricted stock Grants issued from 8/16/2021 through 2/24/2025	US Physical Therapy (issuer)			650	08/20/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities does the USPH Form 144 propose to sell?

The notice proposes to sell 2,000 Class A common shares of US Physical Therapy Inc on the NYSE.

Who is the broker handling the proposed sale in the Form 144?

The broker named is J.P. Morgan Securities LLC located at 390 Madison Avenue, New York, NY.

How were the 2,000 shares acquired according to the filing?

All 2,000 shares were acquired through vesting of restricted stock grants issued between 8/16/2021 and 2/24/2025, across three vesting dates.

What is the aggregate market value and approximate sale date listed?

The aggregate market value is listed as $169,570.50 and the approximate date of sale is 08/19/2025.

How large is the proposed sale relative to outstanding shares?

The filing reports 15,094,987 shares outstanding; the proposed 2,000-share sale is roughly 0.013% of that total.